Patterns of year-to-year variation in haemoglobin and glucose concentrations in the blood of nestling Pied Flycatchers Ficedula hypoleuca

Physiological tools can be used to identify the sources and consequences of stressors on animals. Understanding the influences of variation in habitat quality and anthropogenic disturbance on organism condition and health may improve future management and conservation. We present results concerning variation in haemoglobin and glucose concentrations in the blood of about 14-day-old nestling Pied FlycatchersFicedula hypoleuca in central Poland over a 4-year period, 2011–2014, in a deciduous forest. The most important findings of the study are: (1) the concentration of haemoglobin and glucose of the nestlings from the same brood tended to be consistently similar, with much variation occurring among broods; (2) repeatability of haemoglobin concentration was higher than repeatability of glucose concentration; (3) mean levels of haemoglobin and glucose varied among years; (4) haemoglobin and glucose concentrations were negatively correlated; and (5) there was a positive relationship between haemoglobin levels and breeding success.All procedures were approved by the Local Ethical Committee and the State Office for Environment Protection. We thank A. Jaksa, D. Man´kowska, M. Janiszewska and J. Białek for their help and consent in conducting research in the areas under their administration. The study was founded by a grant from the Polish Ministry of Science and Higher Education No. N N304 045136 and University of Ło´dz´ (No. 506/829). We are obliged to P. Procter for linguistic consultation. We thank both reviewers for their valuable and constructive comments

O badatelkách a badaczkach, vědkyních a naukowczyniach

Článek je věnován lexikálním jednotkám označujícím ženu, která se zabývá vědou. Pozornost je zaměřena na rozdíly mezi češtinou a polštinou, a to zejména na syntaktické a sémantické úrovni (možnosti vyjádření oboru činnosti a tvaru takového vyjádření), dále v oblasti slovotvorné (nízká míra užití polského fem. naukowczyni oproti naukowiec, víceslovná vyjádření apod.). Analýza je založena na příkladech z elektronických korpusů textů (Český národní korpus, vč. InterCorpu, Narodowy Korpus Języka Polskiego) ve srovnání s hesly ve slovnících různého typu.This article focuses on lexical units denoting a female scientist in Polish and Czech. It draws attention to differences between the two languages, especially at the syntactic and semantic levels (the possibility of expressing the field of specialisation of a female scientist and the form of such an expression), as well as the level of word formation (low frequency of the use of fem. naukowczyni as opposed to masc. naukowiec in Polish, multi-word expressions, etc.). The study is based on the analysis of concordances in text corpora (the Czech National Corpus, including InterCorp, and the National Corpus of Polish) in comparison with the data available in various dictionaries

The occurrence of the third trochanter and its correlation to certain anthropometric parameters of the human femur

The purpose of the study was to analyse the occurrence of the third trochanter and its correlation with the morphology of the human femur. The third trochanter was found in 38 of 622 (6.2%) human femora taken from 3 excavation sites. 36 of these were included in the study and were compared to the femora without the third trochanter. The bones with the third trochanter were characterised by a greater superior sagittal diameter and diaphysis platymetry index as well as a larger greater trochanter. These results suggest that the third trochanter is not a progressive morphological feature of the skeleton. Rather it is connected with an altered gluteal muscle function

Evaluation of bone mineral density on the basis of the results of studies of selected skeleton populations from the microregion of Brześć Kujawski

Wstęp: Osteoporoza to systemowa choroba układu kostnego charakteryzująca się obniżeniem wytrzymałości kości, co prowadzi do zwiększonego ryzyka złamań. Wytrzymałość kości jest pochodną gęstości mineralnej kości (BMD, bone mineral density) i jakości tkanki kostnej. Osteoporoza stanowi duży problem medyczny ze względu na powikłania w postaci najczęściej występujących złamań kręgosłupa, dalszej części przedramienia, a w późniejszym okresie życia szyjki kości udowej. Obniżenie BMD stanowi niezależny czynnik ryzyka osteoporozy. Celem pracy była ocena gęstości mineralnej kośćca ludności pochodzącej z okresu obejmującego czas od XI do początku XIX wieku z mikroregionu Brześcia Kujawskiego. Materiał i metody: Badaniom poddano ludzkie kości z czterech stanowisk archeologicznych: Kolonia (XI-XIII), SBK-4 (XII-XVI), Fara (XIV-XVII) oraz Święty Duch (XVI-XIX) uzyskane z wykopalisk i pochodzące za zbiorów Katedry Antropologii Uniwersytetu Łódzkiego. Gęstość mineralną kości populacji szkieletowych porównano z grupą kontrolną, którą stanowiła ludność współczesna z regionu województwa łódzkiego. Występowanie osteoporozy oceniano na podstawie badań wykonanych techniką DXA.Wyniki: Przeprowadzone pomiary densytometryczne pozwoliły stwierdzić różnice w gęstości mineralnej tkanki kostnej. Badane grupy szkieletowe charakteryzowała znamiennie wyższa średnia BMD w porównaniu z grupą współczesną. Zmiany gęstości mineralnej wskazujące na osteopenię w większości odnotowano u kobiet. Wnioski: Na podstawie uzyskanych wyników nie można jednoznaczne stwierdzić, że badane grupy szkieletowe, mimo iż charakteryzują się znamiennie wyższą gęstością mineralną kości, były obarczone niższym ryzykiem występowania osteoporozy i jej powikłań. Wymagana jest kontynuacja badań składu mineralnego kości i ich korelacji z gęstością mineralną kości.Introduction: Osteoporosis is a systemic disease of the skeletal system characterised by reduced bone strength leading to increased risk of fracture. Bone strength is a combined derivative of bone mineral density (BMD) and of bone tissue quality. Osteoporosis is a serious medical problem because of its complications, most frequently manifesting itself in spine fractures, fractures of distal sections of the forearm and, in later periods of life, hip fractures. Reduced BMD is an independent risk factor of osteoporosis. The goal of the study was an evaluation of bone mineral density of the population inhabiting the micro-region of Brześć Kujawski from the 11th century until the beginning of the 19th century. Material and methods: Human bones obtained from archaeological excavations at four archaeological sites: Kolonia (11th–13th centuries), SBK-4 (12th–16th centuries), Fara (14th–17th centuries) and Święty Duch (16th–19th centuries) and from the collections of the Katedra of Anthropology of the University of Łódź were subjected to study. Bone mineral densities of the skeleton populations were compared with those of the control group, namely the present living population of the Łódź Province. The incidence of osteoporosis was evaluated by densitometric assessment, which was performed by dual energy X-ray absorptiometry (DXA) on a DPX device (LUNAR, USA).Results: The densitometric measurements performed enabled differences to be identified in the mineral density of the osseous tissue. The skeletal groups studied were characterised by a significantly higher mean BMD than the contemporary living population. Changes in BMD indicative of osteopenia prevailed in women. Conclusions: On the basis of the results obtained it cannot definitively be stated that the skeletal groups studied, despite their significantly higher BMD, were affected by a lower risk of osteoporosis and its complications. A continuation of studies on the mineral content of bones and on the relationship between the mineral content and bone mineral density is required

Specialist Community Nurses: A Critical Analysis of Their Role in the Management of Long-Term Conditions

The aim of this narrative review is to identify strategies in use by specialist community and public health nurses in the prevention, care and management of individuals with long-term conditions, specifically chronic obstructive pulmonary disease (COPD) and musculoskeletal disorders. These conditions have been selected as they are highly prevalent; a burden on health services globally and a major public health issue. From a UK policy perspective, specialist community nurses have been placed at the forefront of taking a lead role in the coordination and delivery of more responsive services for individuals with long-term conditions; whether this has been an effective use of skills and resource is questionable. We systematically searched relevant databases between 1999–2009 to identify interventions used by specialist community nurses and critically appraised the studies. This review reports on impact and value of interventions used by specialist community nurses in the prevention and management of COPD and musculoskeletal conditions, and makes recommendations for improving services

Circulating serum miR-362-3p and miR-6721-5p as potential biomarkers for classification patients with adult-type diffuse glioma

According to the fifth edition of the WHO Classification of Tumours of the Central Nervous System (CNS) published in 2021, grade 4 gliomas classification includes IDH-mutant astrocytomas and wild-type IDH glioblastomas. Unfortunately, despite precision oncology development, the prognosis for patients with grade 4 glioma remains poor, indicating an urgent need for better diagnostic and therapeutic strategies. Circulating miRNAs besides being important regulators of cancer development could serve as promising diagnostic biomarkers for patients with grade 4 glioma. Here, we propose a two-miRNA miR-362-3p and miR-6721-5p screening signature for serum for non-invasive classification of identified glioma cases into the highest-grade 4 and lower-grade gliomas. A total of 102 samples were included in this study, comprising 78 grade 4 glioma cases and 24 grade 2–3 glioma subjects. Using the NanoString platform, seven miRNAs were identified as differentially expressed (DE), which was subsequently confirmed via RT-qPCR analysis. Next, numerous combinations of DE miRNAs were employed to develop classification models. The dual panel of miR-362-3p and miR-6721-5p displayed the highest diagnostic value to differentiate grade 4 patients and lower grade cases with an AUC of 0.867. Additionally, this signature also had a high AUC = 0.854 in the verification cohorts by RT-qPCR and an AUC = 0.842 using external data from the GEO public database. The functional annotation analyses of predicted DE miRNA target genes showed their primary involvement in the STAT3 and HIF-1 signalling pathways and the signalling pathway of pluripotency of stem cells and glioblastoma-related pathways. For additional exploration of miRNA expression patterns correlated with glioma, we performed the Weighted Gene-Co Expression Network Analysis (WGCNA). We showed that the modules most associated with glioma grade contained as many as six DE miRNAs. In conclusion, this study presents the first evidence of serum miRNA expression profiling in adult-type diffuse glioma using a classification based on the WHO 2021 guidelines. We expect that the discovered dual miR-362-3p and miR-6721-5p signatures have the potential to be utilised for grading gliomas in clinical applications

Avian Feathers as Bioindicators of the Exposure to Heavy Metal Contamination of Food

The aim of this study was to determine the possibility of using feathers of blue tit nestlings to assess the level of endogenous accumulation of lead. For this purpose we conducted an experiment with lead application to randomly chosen nestlings from eight randomly drawn broods. Five days after the exposure, feathers of lead-treated nestlings had significantly higher lead concentrations than control nestlings. This result suggests that feathers can be used as reliable non-destructive bioindicators to assess the level of heavy metals originating from contaminated food, which is of great significance for comparative studies on ecological consequences of pollution

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. For example, a key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process versus those that measure fl ux through the autophagy pathway (i.e., the complete process including the amount and rate of cargo sequestered and degraded). In particular, a block in macroautophagy that results in autophagosome accumulation must be differentiated from stimuli that increase autophagic activity, defi ned as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (inmost higher eukaryotes and some protists such as Dictyostelium ) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the fi eld understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. It is worth emphasizing here that lysosomal digestion is a stage of autophagy and evaluating its competence is a crucial part of the evaluation of autophagic flux, or complete autophagy. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. Along these lines, because of the potential for pleiotropic effects due to blocking autophagy through genetic manipulation it is imperative to delete or knock down more than one autophagy-related gene. In addition, some individual Atg proteins, or groups of proteins, are involved in other cellular pathways so not all Atg proteins can be used as a specific marker for an autophagic process. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field

Early discharge hospital at home.

BACKGROUND: Early discharge hospital at home is a service that provides active treatment by healthcare professionals in the patient's home for a condition that otherwise would require acute hospital inpatient care. This is an update of a Cochrane review. OBJECTIVES: To determine the effectiveness and cost of managing patients with early discharge hospital at home compared with inpatient hospital care. SEARCH METHODS: We searched the following databases to 9 January 2017: the Cochrane Effective Practice and Organisation of Care Group (EPOC) register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, and EconLit. We searched clinical trials registries. SELECTION CRITERIA: Randomised trials comparing early discharge hospital at home with acute hospital inpatient care for adults. We excluded obstetric, paediatric and mental health hospital at home schemes.   DATA COLLECTION AND ANALYSIS: We followed the standard methodological procedures expected by Cochrane and EPOC. We used the GRADE approach to assess the certainty of the body of evidence for the most important outcomes. MAIN RESULTS: We included 32 trials (N = 4746), six of them new for this update, mainly conducted in high-income countries. We judged most of the studies to have a low or unclear risk of bias. The intervention was delivered by hospital outreach services (17 trials), community-based services (11 trials), and was co-ordinated by a hospital-based stroke team or physician in conjunction with community-based services in four trials.Studies recruiting people recovering from strokeEarly discharge hospital at home probably makes little or no difference to mortality at three to six months (risk ratio (RR) 0.92, 95% confidence interval (CI) 0.57 to 1.48, N = 1114, 11 trials, moderate-certainty evidence) and may make little or no difference to the risk of hospital readmission (RR 1.09, 95% CI 0.71 to 1.66, N = 345, 5 trials, low-certainty evidence). Hospital at home may lower the risk of living in institutional setting at six months (RR 0.63, 96% CI 0.40 to 0.98; N = 574, 4 trials, low-certainty evidence) and might slightly improve patient satisfaction (N = 795, low-certainty evidence). Hospital at home probably reduces hospital length of stay, as moderate-certainty evidence found that people assigned to hospital at home are discharged from the intervention about seven days earlier than people receiving inpatient care (95% CI 10.19 to 3.17 days earlier, N = 528, 4 trials). It is uncertain whether hospital at home has an effect on cost (very low-certainty evidence).Studies recruiting people with a mix of medical conditionsEarly discharge hospital at home probably makes little or no difference to mortality (RR 1.07, 95% CI 0.76 to 1.49; N = 1247, 8 trials, moderate-certainty evidence). In people with chronic obstructive pulmonary disease (COPD) there was insufficient information to determine the effect of these two approaches on mortality (RR 0.53, 95% CI 0.25 to 1.12, N = 496, 5 trials, low-certainty evidence). The intervention probably increases the risk of hospital readmission in a mix of medical conditions, although the results are also compatible with no difference and a relatively large increase in the risk of readmission (RR 1.25, 95% CI 0.98 to 1.58, N = 1276, 9 trials, moderate-certainty evidence). Early discharge hospital at home may decrease the risk of readmission for people with COPD (RR 0.86, 95% CI 0.66 to 1.13, N = 496, 5 trials low-certainty evidence). Hospital at home may lower the risk of living in an institutional setting (RR 0.69, 0.48 to 0.99; N = 484, 3 trials, low-certainty evidence). The intervention might slightly improve patient satisfaction (N = 900, low-certainty evidence). The effect of early discharge hospital at home on hospital length of stay for older patients with a mix of conditions ranged from a reduction of 20 days to a reduction of less than half a day (moderate-certainty evidence, N = 767). It is uncertain whether hospital at home has an effect on cost (very low-certainty evidence).Studies recruiting people undergoing elective surgeryThree studies did not report higher rates of mortality with hospital at home compared with inpatient care (data not pooled, N = 856, low-certainty evidence; mainly orthopaedic surgery). Hospital at home may lead to little or no difference in readmission to hospital for people who were mainly recovering from orthopaedic surgery (N = 1229, low-certainty evidence). We could not establish the effects of hospital at home on the risk of living in institutional care, due to a lack of data. The intervention might slightly improve patient satisfaction (N = 1229, low-certainty evidence). People recovering from orthopaedic surgery allocated to early discharge hospital at home were discharged from the intervention on average four days earlier than people allocated to usual inpatient care (4.44 days earlier, 95% CI 6.37 to 2.51 days earlier, , N = 411, 4 trials, moderate-certainty evidence). It is uncertain whether hospital at home has an effect on cost (very low-certainty evidence). AUTHORS' CONCLUSIONS: Despite increasing interest in the potential of early discharge hospital at home services as a less expensive alternative to inpatient care, this review provides insufficient evidence of economic benefit (through a reduction in hospital length of stay) or improved health outcomes